Search

everythinglearnresearchcommunity

for

Search:↓

UK courts and the European Patent Office are now more open to granting patents for new dosage regimes.

3D skin bioprinting, using skin bioinks like collagen and gelatin, is growing fast and could help treat wounds, burns, and skin cancers, as well as test cosmetics and drugs.

Drug repurposing shows promise for treating many medical conditions.

The UK High Court revoked Lundbeck's patent for Escitalopram, and second medical use claims based on dosage were not considered novel.

The document reviews 20 U.S. patents from July and August 2004 about new drug forms, cancer treatments, aroma chemicals, statin drugs, and various chemical production methods.

The compounds tested could potentially treat hair loss and alopecia.

Finasteride in male rats causes liver and metabolic issues in their offspring.

Recent legal rulings favored Genentech, Teva, and upheld guidelines for patent term extensions.

The UK Court of Appeal ruled that new dosing regimens for drugs can be patented, aligning with the European Patent Office's approach.

European patent law now allows patents for new uses and dosages of known drugs, but protection scope is unclear.

The document suggests creating a secure database for indigenous knowledge and recommends that the TKDL actively fight patents that slightly alter traditional knowledge.

The document updates on EU legal changes, including pharmaceutical patents, class actions in Italy, and various drug-related rulings.

Familial factors affect hair loss types in Koreans, with M type in men, L type in women, and paternal factors influencing male hair loss more.

Drug repurposing speeds up development, cuts costs, and uses known safe drugs, but faces challenges like regulations and patents.

Europe strengthened medicine regulations, increased protection against counterfeit drugs, and made it tougher to challenge comparative advertising, while also focusing on patent law enforcement and updating plant protection rules.

Male pattern hair loss may have evolved to promote younger fathers for offspring health and survival, encouraging monogamy and paternal nurturing.

The BASP classification is effective for diagnosing pattern hair loss in Indian men and women.

Early onset hair loss in young men is common and linked to family history and alcohol use.

Eating habits may affect the duration of male pattern baldness.

Diabetic patients often have ingrown nails due to obesity, high blood pressure, past injuries, bad nail trimming, nail fungus, weak foot pulse, and weak knee reflex.

Iron supplements may reverse premature graying in iron-deficient individuals; ingrown nails are common in diabetics with certain risk factors; topical finasteride may reduce scalp DHT as effectively as oral finasteride; monilethrix treatment is challenging but some medications can help.

Genetic discoveries are key for understanding, diagnosing, and treating inherited hair and nail disorders.

Alopecia Areata is an autoimmune disease causing hair loss in patches, often starting before age 20, and while some cases recover on their own, treatments include topical corticosteroids, minoxidil, and promising new methods like IL-31 antibodies and 308-nm Excimer laser therapy.

Microemulsions could improve how drugs are delivered and absorbed in the body.

Healthcare providers should start with simple fertility tests and treatments before referring patients to specialists.

QR 678 and QR678 Neo treatments are effective for hair loss in women with PCOS.

QR678 Neo® improved seborrheic dermatitis symptoms in a small group of patients.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.